Mehmet Akçe

Mehmet Akçe

Emory University - Atlanta / United States
Medical and Health Sciences / Medical Oncology
AD Scientific Index ID: 1357097
person_outline Mehmet Akçe's MOST POPULAR ARTICLES
1-) Pembrolizumab in combination with gemcitabine and cisplatin compared with gemcitabine and cisplatin alone for patients with advanced biliary tract cancer (KEYNOTE-966): a … The Lancet 401 (10391), 1853-1865, 2023
2-) Immune checkpoint inhibitors for the treatment of MSI-H/MMR-D colorectal cancer and a perspective on resistance mechanisms British journal of cancer 121 (10), 809-818, 2019
3-) Lenvatinib plus pembrolizumab versus lenvatinib plus placebo for advanced hepatocellular carcinoma (LEAP-002): a randomised, double-blind, phase 3 trial The lancet oncology 24 (12), 1399-1410, 2023
4-) The prognostic and predictive impact of inflammatory biomarkers in patients who have advanced‐stage cancer treated with immunotherapy Cancer 125 (1), 127-134, 2019
5-) The potential of CAR T cell therapy in pancreatic cancer Frontiers in immunology 9, 2166, 2018